(NASDAQ: MLEC) Moolec Science Sa's forecast annual revenue growth rate of -25.97% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.07%.
Moolec Science Sa's revenue in 2026 is $335,108,850.On average, 3 Wall Street analysts forecast MLEC's revenue for 2026 to be $95,912,847, with the lowest MLEC revenue forecast at $92,144,298, and the highest MLEC revenue forecast at $98,733,813. On average, 3 Wall Street analysts forecast MLEC's revenue for 2027 to be $859,109,432, with the lowest MLEC revenue forecast at $825,410,324, and the highest MLEC revenue forecast at $884,378,318.
In 2028, MLEC is forecast to generate $1,452,852,000 in revenue, with the lowest revenue forecast at $1,395,779,172 and the highest revenue forecast at $1,495,547,703.